World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
120
Citations
49262
World Ranking
3776
National Ranking
2074

Overview

Tracy T. Batchelor is affiliated with Brigham and Women's Hospital in the United States. Their research primarily focuses on medicine, with a significant emphasis on genetics, radiology, nuclear medicine and imaging, neurology, oncology, and pulmonary and respiratory medicine.

The main topics of their work highlight key areas such as glioma diagnosis and treatment, CNS lymphoma diagnosis and treatment, advanced MRI techniques and applications, lymphoma diagnosis and treatment, brain metastases and treatment, radiomics and machine learning in medical imaging, and cancer genomics and diagnostics.

Tracy T. Batchelor has contributed extensively to several publication venues, with numerous papers in Neuro-Oncology, Journal of Clinical Oncology, Neuro-Oncology Advances, Blood, and conference proceedings related to magnetic resonance in medicine.

Some of their recent papers include:

  • Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions (2020, Neuro-Oncology)
  • Mechanisms and therapeutic implications of hypermutation in gliomas (2020, Nature)
  • Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system (2021, Cancer)
  • Cancer neuroscience: State of the field, emerging directions (2023, Cell)
  • Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma (2020, Nature Genetics)

The scientist frequently collaborates with colleagues such as Jörg Dietrich, Patrick Y. Wen, Eudocia Q. Lee, Ugonma Chukwueke, and Daniel P. Cahill, indicating a broad network of co-authorship within their field.

Best Publications

  • AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients

    Tracy T. Batchelor;A. Gregory Sorensen;A. Gregory Sorensen;Emmanuelle di Tomaso;Wei Ting Zhang;Wei Ting Zhang

  • An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma

    Cyril Neftel;Julie Laffy;Mariella G. Filbin;Toshiro Hara

  • Angiogenesis in brain tumours

    Rakesh K. Jain;Emmanuelle di Tomaso;Dan G. Duda;Jay S. Loeffler

  • Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.

    Catherine L. Nutt;D. R. Mani;Rebecca A. Betensky;Pablo Tamayo

  • Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets

    Priscilla K. Brastianos;Scott L. Carter;Scott L. Carter;Sandro Santagata;Sandro Santagata;Daniel P. Cahill

  • Report of an International Workshop to Standardize Baseline Evaluation and Response Criteria for Primary CNS Lymphoma

    Lauren E. Abrey;Tracy T. Batchelor;Andrés J.M. Ferreri;Mary Gospodarowicz

  • Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions

    Patrick Y. Wen;Michael Weller;Eudocia Quant Lee;Brian M. Alexander

  • Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq

    Mariella G. Filbin;Itay Tirosh;Itay Tirosh;Volker Hovestadt;Volker Hovestadt;McKenzie L. Shaw;McKenzie L. Shaw

  • Biomarkers of response and resistance to antiangiogenic therapy.

    Rakesh K. Jain;Dan G. Duda;Christopher G. Willett;Dushyant V. Sahani

  • Mechanisms and therapeutic implications of hypermutation in gliomas.

    Mehdi Touat;Mehdi Touat;Mehdi Touat;Yvonne Y. Li;Yvonne Y. Li;Adam N. Boynton;Adam N. Boynton;Liam F. Spurr;Liam F. Spurr

  • Treatment of Primary CNS Lymphoma With Methotrexate and Deferred Radiotherapy: A Report of NABTT 96–07

    Tracy Batchelor;Kathryn Carson;Alison O’Neill;Stuart A. Grossman

  • Phase III Randomized Trial Comparing the Efficacy of Cediranib As Monotherapy, and in Combination With Lomustine, Versus Lomustine Alone in Patients With Recurrent Glioblastoma

    Tracy T Batchelor;Paul Mulholland;Bart Neyns;L Burt Nabors

  • Phase II Study of Cediranib, an Oral Pan–Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent Glioblastoma

    Tracy T. Batchelor;Dan G. Duda;Emmanuelle di Tomaso;Marek Ancukiewicz

  • Strategies to advance translational research into brain barriers

    Edward Neuwelt;N Joan Abbott;Lauren Abrey;William A Banks

  • Primary Vitreoretinal Lymphoma: A Report from an International Primary Central Nervous System Lymphoma Collaborative Group Symposium

    Chi Chao Chan;James L. Rubenstein;Sarah E. Coupland;Janet L. Davis

  • Primary CNS Lymphoma

    Tracy Batchelor;Jay S. Loeffler

  • Randomized Trial of a Slow-Release Versus a Standard Formulation of Cytarabine for the Intrathecal Treatment of Lymphomatous Meningitis

    Michael J. Glantz;Suzanne LaFollette;Kurt A. Jaeckle;William Shapiro

  • Loss of the Mismatch Repair Protein MSH6 in Human Glioblastomas Is Associated with Tumor Progression during Temozolomide Treatment

    Daniel P. Cahill;Kymberly K. Levine;Rebecca A. Betensky;Patrick J. Codd

  • A Hypermutation Phenotype and Somatic MSH6 Mutations in Recurrent Human Malignant Gliomas after Alkylator Chemotherapy

    Chris Hunter;Raffaella Smith;Daniel P. Cahill;Philip Stephens

  • Detection of 2-Hydroxyglutarate in IDH-Mutated Glioma Patients by In Vivo Spectral-Editing and 2D Correlation Magnetic Resonance Spectroscopy

    Ovidiu C. Andronesi;Grace S. Kim;Elizabeth Gerstner;Tracy Batchelor

Frequent Co-Authors

Patrick Y. Wen
Patrick Y. Wen Harvard University
Rakesh K. Jain
Rakesh K. Jain Harvard University
David N. Louis
David N. Louis Harvard University
David A. Reardon
David A. Reardon Harvard University
Keith L. Ligon
Keith L. Ligon Harvard University
Stuart A. Grossman
Stuart A. Grossman Johns Hopkins University
Dan G. Duda
Dan G. Duda Harvard University
Rameen Beroukhim
Rameen Beroukhim Harvard University
Bruce R. Rosen
Bruce R. Rosen Harvard University
David Schiff
David Schiff University of Virginia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in medicine but looking for flexible study options or alternative career pathways? There are a variety of online degrees available to help you enter or advance within the healthcare field. Programs offering medical billing and coding training are a popular entry point, and many prospective students research how much is medical billing and coding school to determine affordability and return on investment.

Nursing is another in-demand field with many online education options. If you’re aiming to become an advanced practice nurse, you should explore the cheapest fnp programs that can prepare you for a dynamic role as a family nurse practitioner. Those considering entry-level or bridge nursing programs often want to know how much is online nursing school to compare costs across accredited institutions.

For nurses looking to move into leadership, research, or academic roles, an online doctoral degree may be the next step. You can learn more about these advanced opportunities by reviewing the most accessible programs for a phd in nursing.

Best Scientists Citing Tracy T. Batchelor

Trending Scientists

Recently Published Articles